The board of directors of China Healthwise Holdings Limited announced that, based on the preliminary assessment of the unaudited consolidated management accounts of the Group for the six months ended 30 September 2017, the Group is expected to record a significant increase in loss attributable to equity holders of the Company for the six months ended 30 September 2017 as compared to a loss attributable to equity holders of the Company of HKD 24.2 million for the six months ended 30 September 2016. The expected increase in loss is mainly attributable to an increase of impairment loss of available-for-sale investments.